Hormone replacement therapy: A possible risk factor in carriers of familial pulmonary hypertension [7]

Chest

Volumn 116, Issue 3, 1999, Pages 847-

  Morse, J H ^a   Hornrobyn, E M ^a   Barst, J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; CASE REPORT; CHROMOSOME 2Q; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FAMILIAL DISEASE; FEMALE; HIGH RISK PATIENT; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; LETTER; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; THORAX RADIOGRAPHY;

EID: 0032822978     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.3.847     Document Type: Letter

References (6)

1. RE Kleiger M Boxer RE Ingham Pulmonary hypertension in patients using oral contraceptives Chest 69 1976 143 147
2. N Irey H Norris Intimal vascular lesions associated with female reproductive steroids Arch Pathol 96 1973 227 234
3. JH Morse AC Jones RJ Barst Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31–32 Circulation 95 1997 2603 2606
4. WC Nichols DL Koller B Slovis Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32 Nat Genet 15 1997 277 280
5. World Health Organization WHO World Symposium: Primary Pulmonary Hypertension 1998; summary Available at: http://www.who.int/ncd/cvd/pph.html Accessed: December 15, 1998
6. JH Morse RJ Barst Detection of familial primary pulmonary hypertension by genetic testing N Engl J Med 337 1997 202 203